Serawin Biologicals LLP
About Serawin Biologicals LLP
Data last updated:
Serawin Biologicals LLP is a limited liability partnership (LLP) based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 January 2016 and has been in existence for over 10 years.
The LLP is registered with the Registrar of Companies (ROC), Hyderabad, under LLPIN AAF-5909. Its GSTIN is 36ACZFS3599M1ZR (Telangana).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Jaya Daga and Siddarth Daga.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 806 Essjay House Road No.3 Banjara Hills, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹6.38 Cr, a decline of 15% compared to the previous year. For the same year it recorded a net profit of ₹17.33 Lakh (net margin 2.7%) and EBITDA of ₹58.25 Lakh (EBITDA margin 9.1%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 21% over five years.
The LLP has about 9 employees on its provident fund (EPFO) records.
Company details
Contact details
Serawin Biologicals LLP's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address806 Essjay House Road No.3 Banjara Hills, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Serawin Biologicals LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Serawin Biologicals LLP
FY 2025 filings availableSerawin Biologicals LLP reported revenue of ₹6.38 Cr (down 15% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 21% over five years, including a 15% fall in the latest year. EBITDA fell 57% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹17.33 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 2.7% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Serawin Biologicals LLP, buy the company report.
Designated partners of Serawin Biologicals LLP
Serawin Biologicals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jaya Daga | Designated Partner | 08 Dec 2022 | 3 Years 10 Months | Current |
| Siddarth Daga | Designated Partner | 29 Jan 2016 | 10 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Serawin Biologicals LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Serawin Biologicals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Serawin Biologicals LLP has a workforce of 9 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Serawin Biologicals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ACZFS3599M1ZR | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Serawin Biologicals LLP, buy the company report.
Recent activity
Serawin Biologicals LLP has 2 designated partner changes on record since 2016: 2 appointments. The latest: Jaya Daga was appointed as Designated Partner on 08 Dec 2022.
Frequently asked questions
Serawin Biologicals is an active limited liability partnership based in Hyderabad, Telangana, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 29 January 2016 (10+ years old) and is registered under LLPIN AAF-5909.
Serawin Biologicals has 2 current designated partners:
- Jaya Daga - Designated Partner
- Siddarth Daga - Designated Partner
The latest financial statements of Serawin Biologicals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Serawin Biologicals is 36ACZFS3599M1ZR, registered in Telangana.
The LLPIN (Limited Liability Partnership Identification Number) of Serawin Biologicals is AAF-5909. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Serawin Biologicals was incorporated on 29 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Jaya Daga was appointed as Designated Partner on 08 Dec 2022. Siddarth Daga was appointed as Designated Partner on 29 Jan 2016.
The registered office of Serawin Biologicals is at 806 Essjay House Road No.3 Banjara Hills, Hyderabad, Telangana, India – 500034.
Serawin Biologicals operates in the pharma industry, in the drug formulation and development segment.
Serawin Biologicals can be reached at its registered office: 806 Essjay House Road No.3 Banjara Hills, Hyderabad, Telangana, India – 500034.